Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone dose comparison for nausea, vomiting, and blood glucose after cesarean section
IRCT20260225068947N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of dexamethasone in postoperative nausea and vomiting (PONV) (3 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Nausea within 24 hours after cesarean section, Vomiting within 24 hours after cesarean section and 1 more. Started Apr 2026; status: completed.
02
Drugs
dexamethasone
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20260225068947N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260225068947N1.